USRE39221E1 - Composition comprising a tramadol material and acetaminophen and its use - Google Patents

Composition comprising a tramadol material and acetaminophen and its use Download PDF

Info

Publication number
USRE39221E1
USRE39221E1 US10/761,096 US76109604A USRE39221E US RE39221 E1 USRE39221 E1 US RE39221E1 US 76109604 A US76109604 A US 76109604A US RE39221 E USRE39221 E US RE39221E
Authority
US
United States
Prior art keywords
pharmaceutical composition
tramadol
acetaminophen
form
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US10/761,096
Inventor
Robert B. Raffa
Jeffrey L. Vaught
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US75592491A priority Critical
Priority to US07/974,865 priority patent/US5336691A/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36710719&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=USRE39221(E1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Priority to US10/761,096 priority patent/USRE39221E1/en
Assigned to ORTHO-MCNEIL PHARAMACEUTICAL, INC. reassignment ORTHO-MCNEIL PHARAMACEUTICAL, INC. MERGER (SEE DOCUMENT FOR DETAILS). Assignors: MCNEILAB, INC., ORTHO PHARMACUETICAL CORPORATION
Assigned to ORTHO-MCNEIL PHARMACEUTICAL, INC. reassignment ORTHO-MCNEIL PHARMACEUTICAL, INC. CORRECTIVE ASSIGNMENT TO CORRECT THE FIRST ASSIGNOR: "PHARMACUETICAL" SHOULD READ "PHARMACEUTICAL" AND ASSIGNEE: "PHARAMEUTICAL" SHOULD READ "PHARMACEUTICAL" PREVIOUSLY RECORDED ON REEL 017507 FRAME 0355. ASSIGNOR(S) HEREBY CONFIRMS THE CONVEYING AND RECEIVING PARTY DATA CONTAIN A TYPOGRAPHICAL ERROR. Assignors: MCNEILAB, INC., ORTHO PHARMACEUTICAL CORPORATION
Publication of USRE39221E1 publication Critical patent/USRE39221E1/en
Application granted granted Critical
Assigned to ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS, INC. reassignment ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS, INC. AGREEMENT FOR TRANSFER OF ASSETS AND BILL OF SALE Assignors: ORTHO-MCNEIL PHARMACEUTICAL, INC.
Anticipated expiration legal-status Critical
Application status is Expired - Lifetime legal-status Critical

Links